Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373679 · ClinicalTrials.gov registry record · NA
Switch or Quit R01
A NA study of Cigarette Smoking and Smoking Behaviors, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 1
- Study location
NCT06373679: Recruiting NA study of Cigarette Smoking and Smoking Behaviors, sponsored by Medical University of South Carolina.
NCT06373679 is a NA study of Cigarette Smoking and Smoking Behaviors that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 225 participants, above the 171-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (32% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06373679, a NA study of Cigarette Smoking and Smoking Behaviors, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates whether non-cigarette tobacco products (e-cigarettes) can help smokers quit smoking as compared to traditional quit methods (nicotine replacement therapy or varenicline/Chantix). Participants in this study will be randomly assigned to one of two groups, then will have a choice between the offered products of that group. Participants in the e-cigarette group will have a choice of e-cigarette brand and flavor. Participants in the medication group will have choice between nicotine replacement therapy (patches and lozenges) or varenicline, also known as Chantix. Participation will last 6 months and will include weekly phone calls for the initial 7-weeks plus a 11-week phone call and a 6-month follow-up visit. Participants will also complete electronic daily diaries during the first 7-weeks.
Primary Outcome
Self-reported zero cigarettes in the past 7 days on timeline followback at Week 11 + expired carbon monoxide \< 6 ppm
Conditions Studied
Interventions
- BEHAVIORAL Switching to E-Cigarette
- BEHAVIORAL Switching using Medication
Study Locations (1)
South Carolina
- Medical Univeristy of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2024-07-10 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What NCT06373679 shows while recruiting
NCT06373679 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, above the 171-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (32% higher).
The record links to 2 conditions, with Cigarette Smoking appearing as the primary indexed condition, and to 2 interventions - of which Switching to E-Cigarette is the first listed.
NCT06373679 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06373679 about?
NCT06373679 is a clinical study titled "Switch or Quit R01". This study evaluates whether non-cigarette tobacco products (e-cigarettes) can help smokers quit smoking as compared to traditional quit methods (nicotine replacement therapy or varenicline/Chantix). Participants in this study will be randomly assigned to one of two groups, then will have a choice b...
What is the current status of trial NCT06373679?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2024-07-10. Estimated completion is 2027-05-01.
What conditions does trial NCT06373679 study?
This clinical trial studies the following conditions: Cigarette Smoking, Smoking Behaviors.
What interventions are being tested in trial NCT06373679?
The interventions under investigation include: Switching to E-Cigarette (BEHAVIORAL), Switching using Medication (BEHAVIORAL).
Who is sponsoring clinical trial NCT06373679?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06373679 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06373679's enrollment target sits among peer trials
225 10th of 45 higher than 36 of 45 other Cigarette Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
RECRUITING · NA
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI